Healthcare company Omega Healthcare Investors Inc (NYSE:OHI) stated on Tuesday its net income of USD72.2m (USD0.34 per common share) for the quarter ended 31 March 2019.
This marks a decrease in earnings when compared with net income of USD87.9m (USD0.42 per common share) for the corresponding period in 2018.
The company added the decline in net income for the quarter ended 31 March 2019 versus the prior year was primarily due to the reduction in gains on the sale of assets, an increase of costs related to the acquisition of MedEquities Realty Trust as well as an increase of of impairments
Operating revenues of USD223.7m were generated for the quarter ended 31 March 2019, up over operating revenues of USD220.2m for the same period in 2018.
CVS Health declares unchanged quarterly dividend
ALK partners with GenSci to expand allergy immunotherapy market in China
Curatis secures Swiss distribution deal with Phoenix Labs
Innocan Pharma reports 'positive swing' in operating profitability for first half of 2025
Wolters Kluwer boosts medical research efficiency with Ovid AI summarisation
European Commission approves Gilead's twice-yearly HIV prevention injection Yeytuo
Essa Pharma clarifies Nasdaq due bill trading period for cash distribution
Advanz Pharma and Alvotech secure European approval for aflibercept biosimilar Mynzepli
Heron Therapeutics announces tax benefits preservation plan adoption
Essa Pharma sets ex-dividend date and due bill trading for USD80m capital return
BioDlink's bevacizumab injection secures Colombia and Pakistan marketing authorisation
GSK to receive USD370m and future royalties in CureVac/BioNTech settlement
Everest Medicines expands I-MAB investment
Perrigo Announces Quarterly Dividend
Ridgetech reports net income of USD10.20m in fiscal year 2025